The protective properties of melatonin against aluminium‐induced neuronal injury

Summary Aluminium (Al) toxicity is closely linked to the pathogenesis of Alzheimer's disease (AD). This experimental study investigated the neuroprotective effect of melatonin (Mel; 10 mg/kg bwt) on aluminium chloride (AlCl3; 34 mg/kg bwt) induced neurotoxicity and oxidative stress in rats. Adult male albino Wistar rats were injected with AlCl3 for 7 days. The effect on brain structure, lipid peroxidation (LPO), nitric oxide (NO) levels, glutathione (GSH) content, antioxidant enzymes (SOD, CAT, GPx and GR), apoptotic proteins (Bax and Bcl‐2) and an apoptotic enzyme (caspase‐3) was investigated. No apparent changes occurred following the injection of melatonin. Melatonin pretreatment of the AlCl3‐administered rats reduced brain damage, and the tissues appeared like those of the control rats. Compared to treatment with AlCl3, pretreatment with melatonin decreased LPO and NO levels and increased the GSH content and antioxidant enzyme activity. Moreover, melatonin increased the levels of the anti‐apoptotic protein, Bcl‐2, decreased the levels of the pro‐apoptotic protein, Bax, and inhibited caspase‐3 activity. Therefore, our results indicate that melatonin may provide therapeutic value against aluminium‐induced oxidative stress and histopathological alternations in the rat brain and that these effects may be related to anti‐apoptotic and antioxidant activities.
Source: International Journal of Experimental Pathology - Category: Pathology Authors: Tags: Original Article Source Type: research